Drug:
Reaction: INFECTION
20250101 - 20251231
No. 101 - 200
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
101 | 25131355 |
US |
36 | 2 |
Systemic lupus erythematosus, Brain fog, Infection, Pleuritic pain, Raynaud^s phenomenon, |
||||
VOCLOSPORIN, |
||||
102 | 25131587 |
US |
58 | 2 |
Diverticulitis, Infection, Tendonitis, Neuropathy peripheral, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
103 | 25131958 |
BR |
76 | 1 |
Pyrexia, Infection, Pneumonia, |
||||
ELRANATAMAB-BCMM, |
||||
104 | 25131963 |
US |
56 | 1 |
Loss of personal independence in daily activities, Pain, Infection, Diarrhoea, |
||||
APREMILAST, |
||||
105 | 25132008 |
US |
69 | 2 |
Surgery, Infection, Infection, |
||||
RISANKIZUMAB-RZAA, |
||||
106 | 25134670 |
53 | 2 | |
Tonsillitis, Infection, Therapy interrupted, |
||||
ETANERCEPT, ETANERCEPT, ETANERCEPT, |
||||
107 | 25134782 |
66 | 2 | |
Infection, Treatment delayed, |
||||
ADALIMUMAB, |
||||
108 | 25121424 |
CA |
1 | |
Diarrhoea, Infection, Inappropriate schedule of product administration, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SULFASALAZINE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
109 | 25121685 |
CN |
52 | 2 |
Pneumocystis jirovecii pneumonia, Epstein-Barr virus infection, Cough, Infection, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
110 | 25122231 |
CA |
79 | 1 |
Asthenia, Condition aggravated, Gait disturbance, Gastrointestinal necrosis, Hospitalisation, Infection, Intestinal resection, |
||||
LEUPROLIDE ACETATE, APALUTAMIDE, |
||||
111 | 25122722 |
CA |
50 | 2 |
Systemic lupus erythematosus, Exposure during pregnancy, Abdominal discomfort, Contusion, Adverse drug reaction, Fibromyalgia, Gait inability, Fatigue, Facet joint syndrome, Dyspnoea, Asthenia, Autoimmune disorder, Folliculitis, Drug intolerance, Asthma, Bursitis, Diarrhoea, Arthropathy, Blood cholesterol increased, Dry mouth, Duodenal ulcer perforation, Anxiety, Dizziness, Contraindicated product administered, Chest pain, Deep vein thrombosis postoperative, Condition aggravated, Arthralgia, C-reactive protein abnormal, Confusional state, Abdominal pain, Abdominal pain upper, Malaise, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Wound, Sciatica, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Gastrointestinal disorder, Hypertension, Discomfort, Impaired healing, Lower respiratory tract infection, Alopecia, Hypersensitivity, Lip dry, C-reactive protein, Lower limb fracture, Anti-cyclic citrullinated peptide antibody positive, Blister, Migraine, Infection, Helicobacter infection, Swollen joint count increased, Decreased appetite, Drug hypersensitivity, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic enzyme increased, Hypoaesthesia, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver disorder, Liver injury, Lung disorder, Red blood cell sedimentation rate increased, Hepatic cirrhosis, Colitis ulcerative, Crohn^s disease, Feeling hot, Ill-defined disorder, Insomnia, Intentional product use issue, Drug ineffective, Off label use, Product use in unapproved indication, Product use issue, Rectal haemorrhage, Retinitis, Therapy non-responder, Oedema, Pyrexia, Medication error, Nausea, Pregnancy, Prescribed overdose, Therapeutic product effect decreased, Treatment failure, Upper respiratory tract infection, Maternal exposure timing unspecified, Oedema peripheral, Sleep disorder, Sleep disorder due to general medical condition, hypersomnia type, Hip arthroplasty, Knee arthroplasty, Maternal exposure during pregnancy, |
||||
IBUPROFEN, DICLOFENAC, DICLOFENAC SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREGABALIN, METHYLPREDNISOLONE SODIUM SUCCINATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DESOXIMETASONE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, CALCIUM CARBONATE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CETRIMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, IBUPROFEN, IBUPROFEN, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREGABALIN, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB, HYALURONIDASE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, ACETAMINOPHEN AND DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN AND CAFFEINE, ACETAMINOPHEN AND PHENYLEPRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ASCORBIC ACID, ASCORBIC ACID, ASCORBIC ACID, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROXYCHLOROQUINE SULFATE, DEXTROMETHORPHAN HYDROBROMIDE, HYDROCORTISONE BUTYRATE, CALCIUM GLUCONATE, GOLIMUMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOCILIZUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, |
||||
112 | 25122747 |
US |
2 | |
Infection, Wrong technique in product usage process, |
||||
DENOSUMAB, |
||||
113 | 25122805 |
GB |
2 | |
Malaise, Rheumatoid arthritis, Headache, Infection, |
||||
TOCILIZUMAB, |
||||
114 | 25122946 |
US |
83 | 2 |
Infection, Off label use, |
||||
POMALIDOMIDE, POMALIDOMIDE, |
||||
115 | 25122964 |
IN |
44 | 1 |
Infection, |
||||
116 | 25123510 |
US |
1 | |
Infection, Oropharyngeal pain, |
||||
ALBUTEROL SULFATE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ROSUVASTATIN CALCIUM, DUPILUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, MONTELUKAST SODIUM, MONTELUKAST, PAROXETINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
117 | 25124033 |
US |
2 | |
Infection, Hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
118 | 25124204 |
CA |
42 | 2 |
Abdominal pain upper, Muscle spasticity, Arthralgia, Vomiting, Lower respiratory tract infection, Weight increased, Infection, Joint swelling, Sinusitis, Night sweats, Respiratory disorder, Stomatitis, Pyrexia, Sleep disorder due to general medical condition, insomnia type, Rash, Dyspnoea, Drug ineffective, Muscle injury, Ill-defined disorder, Insomnia, Ear pain, Contraindicated product administered, Peripheral swelling, Asthenia, Body temperature increased, Pain, Pruritus, Hypersensitivity, Swelling, Nasopharyngitis, Irritable bowel syndrome, Fatigue, Impaired healing, Urticaria, Therapeutic product effect decreased, Blister, Back pain, Headache, Folliculitis, Diarrhoea, Contusion, Confusional state, Gastrointestinal disorder, Sleep disorder, |
||||
METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, GOLIMUMAB, GOLIMUMAB, PANTOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL, ALBUTEROL SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ETANERCEPT, VITAMIN C, ERGOCALCIFEROL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, METHOTREXATE, METHOTREXATE SODIUM, ALBUTEROL SULFATE, ALBUTEROL, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, OXYCODONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LEFLUNOMIDE, LEFLUNOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FISH OIL, LEFLUNOMIDE, |
||||
119 | 25125018 |
1 | ||
Dry mouth, Thirst, Infection, Ageusia, |
||||
UPADACITINIB, |
||||
120 | 25125150 |
IN |
66 | 1 |
Infection, |
||||
SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, |
||||
121 | 25125296 |
CA |
7 | 2 |
Adrenal suppression, Cataract subcapsular, Cushingoid, Cytomegalovirus infection, Drug ineffective, Glomerulosclerosis, Hypertension, Infection, Neuropathy peripheral, Osteoporosis, Proteinuria, Pulmonary toxicity, Renal disorder, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, PROPRANOLOL HYDROCHLORIDE, TRAMETINIB, BLEOMYCIN, BLEOMYCIN SULFATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PREDNISONE, PREDNISONE, SIROLIMUS, SIROLIMUS, SIROLIMUS, SIROLIMUS, |
||||
122 | 25125420 |
ES |
||
Death, Renal failure, Haemorrhage, Drug intolerance, Infection, |
||||
IBRUTINIB, |
||||
123 | 25125467 |
CA |
51 | 2 |
Asthma, Head injury, Illness, Inappropriate schedule of product administration, Infection, Influenza, Pneumonia, Respiratory syncytial virus infection, Dyspnoea, Fall, Dizziness, |
||||
GABAPENTIN, MODAFINIL, MEPOLIZUMAB, MEPOLIZUMAB, MONTELUKAST, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
124 | 25126043 |
US |
2 | |
Infection, Drug ineffective, |
||||
DUPILUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, OXYBUTYNIN CHLORIDE, CRISABOROLE, |
||||
125 | 25126113 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Pemphigus, Pericarditis, Peripheral swelling, Pyrexia, Rheumatoid arthritis, Sinusitis, Sleep disorder, Gastrointestinal disorder, Rash, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Wound, Weight increased, Hepatic enzyme increased, Insomnia, Fatigue, Arthralgia, Pruritus, Hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, APREPITANT, LEFLUNOMIDE, CETRIMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ETANERCEPT, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, OXYCODONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, |
||||
126 | 25128759 |
59 | 1 | |
Illness, Infection, |
||||
UPADACITINIB, |
||||
127 | 25129786 |
|||
Nasopharyngitis, Infection, |
||||
OCRELIZUMAB, |
||||
128 | 25115859 |
US |
1 | |
Platelet count decreased, Full blood count decreased, Increased tendency to bruise, Decreased immune responsiveness, Infection, |
||||
POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, LISINOPRIL, DAPAGLIFLOZIN, |
||||
129 | 25115939 |
CA |
7 | 2 |
Adrenal suppression, Cataract subcapsular, Cushingoid, Cytomegalovirus infection, Glomerulosclerosis, Hypertension, Infection, Neuropathy peripheral, Osteoporosis, Proteinuria, Pulmonary toxicity, Renal disorder, Drug ineffective, |
||||
PROPRANOLOL HYDROCHLORIDE, BLEOMYCIN, BLEOMYCIN SULFATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, OCTREOTIDE ACETATE, OCTREOTIDE, PREDNISONE, PREDNISONE, SIROLIMUS, SIROLIMUS, SIROLIMUS, SIROLIMUS, TRAMETINIB, |
||||
130 | 25116050 |
US |
2 | |
Atypical pneumonia, Psoriasis, Infection, Off label use, |
||||
BIMEKIZUMAB, ERENUMAB-AOOE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, MAGNESIUM, RIZATRIPTAN, TOPIRAMATE, TOPIRAMATE SPINKLE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
131 | 25116530 |
US |
50 | 1 |
Small intestinal obstruction, Gallbladder disorder, Infection, Product use issue, |
||||
AMBRISENTAN, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, |
||||
132 | 25117159 |
US |
||
Pneumonia, Urinary tract infection, Sepsis, Septic shock, Unevaluable event, Postoperative wound infection, Infection, Surgical procedure repeated, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
133 | 25117204 |
US |
1 | |
Infection, Cytokine release syndrome, Neutropenia, Off label use, |
||||
OBINUTUZUMAB, GLOFITAMAB, IBRUTINIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
134 | 25117352 |
US |
2 | |
Back pain, Dysphagia, Aspiration, Infection, Weight decreased, |
||||
OFATUMUMAB, |
||||
135 | 25117524 |
GB |
2 | |
Malaise, Illness, Infection, |
||||
CLOZAPINE, |
||||
136 | 25118160 |
GB |
67 | 1 |
Infection, |
||||
QUIZARTINIB, |
||||
137 | 25118589 |
CA |
2 | |
Drug-induced liver injury, Fibromyalgia, Grip strength decreased, Dislocation of vertebra, Arthropathy, Gait inability, Fatigue, Delirium, Discomfort, Weight increased, Asthma, Systemic lupus erythematosus, Folliculitis, General physical health deterioration, Abdominal discomfort, Wound, Swollen joint count increased, Glossodynia, Bone erosion, Stomatitis, Autoimmune disorder, Bronchitis, Anti-cyclic citrullinated peptide antibody positive, Dizziness, Type 2 diabetes mellitus, Crohn^s disease, Depression, Ear infection, Foot deformity, Alopecia, Arthritis, Vomiting, Blood cholesterol increased, Swelling, Exostosis, Hand deformity, Headache, Anxiety, Dyspnoea, Anti-cyclic citrullinated peptide antibody, Wheezing, Synovitis, Decreased appetite, Tachycardia, Visual impairment, Duodenal ulcer perforation, Blister, Adjustment disorder with depressed mood, Deep vein thrombosis postoperative, Gait disturbance, Chest pain, C-reactive protein increased, Upper respiratory tract infection, Breast cancer stage III, Weight decreased, Urticaria, Condition aggravated, Arthralgia, Confusional state, Diarrhoea, Wound infection, Dyspepsia, Amnesia, Contusion, Disability, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Seronegative arthritis, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Walking aid user, |
||||
CALCIUM CARBONATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, MESALAMINE, ERGOCALCIFEROL, ERGOCALCIFEROL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, PREGABALIN, USTEKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, AZATHIOPRINE, TOFACITINIB, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CERTOLIZUMAB PEGOL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYCODONE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, TRICLOSAN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRAMADOL HYDROCHLORIDE, VEDOLIZUMAB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CLONIDINE HYDROCHLORIDE, CLONIDINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ETANERCEPT, ETANERCEPT, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, GOLIMUMAB, |
||||
138 | 25118660 |
AU |
||
Neoplasm malignant, Lupus-like syndrome, Infection, Vasculitis, Drug specific antibody present, Infusion related reaction, Nausea, Abdominal pain, Fatigue, Arthralgia, Upper respiratory tract infection, Headache, Chest pain, Dyspnoea, Paraesthesia, Psoriasis, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
139 | 25119281 |
CA |
2 | |
Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Lower limb fracture, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Prescribed underdose, Prescribed overdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Nasopharyngitis, Laryngitis, Infection, Helicobacter infection, Lupus vulgaris, Pneumonia, Retinitis, Sinusitis, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
140 | 25119455 |
CA |
2 | |
Pulmonary fibrosis, Insomnia, Impaired healing, Pneumonia, Hypersensitivity, Hypertension, Hypercholesterolaemia, Pruritus, Psoriatic arthropathy, Infusion related reaction, Prescribed overdose, Joint swelling, Peripheral swelling, Pain in extremity, Rheumatic fever, Nasopharyngitis, Osteoporosis, Retinitis, Seronegative arthritis, Memory impairment, Joint range of motion decreased, Laryngitis, Liver injury, Psoriasis, Pemphigus, Sinusitis, Joint dislocation, Spondylitis, Nausea, Injury, Hepatic enzyme increased, Liver function test increased, Lower limb fracture, Helicobacter infection, Red blood cell sedimentation rate increased, Sleep disorder due to a general medical condition, Muscle injury, Musculoskeletal stiffness, Pain, Road traffic accident, Pyrexia, Infection, Irritable bowel syndrome, Osteoarthritis, Sleep disorder, Lupus-like syndrome, Oedema peripheral, Pericarditis, Lupus vulgaris, Hepatic cirrhosis, Hypoaesthesia, Muscular weakness, Mobility decreased, Joint stiffness, Sciatica, Rash, Rheumatoid arthritis, Prescribed underdose, Oedema, Rheumatoid factor positive, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREGABALIN, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
141 | 25119548 |
RU |
78 | |
Bacterial toxaemia, White blood cell count decreased, Infection, |
||||
ZANUBRUTINIB, |
||||
142 | 25119964 |
CN |
7 | 2 |
Myelosuppression, Infection, Pyrexia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MESNA, MESNA INJECTION, MESNA, MESNA INJECTION, MESNA, MESNA INJECTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN HYDROCHLORIDE, |
||||
143 | 25120287 |
JP |
9 | 2 |
Malignant neoplasm progression, Depressed level of consciousness, Disseminated intravascular coagulation, Disorientation, Lymphoedema, Infection, |
||||
PEMBROLIZUMAB, |
||||
144 | 25120331 |
GB |
32 | |
Infection, Lung disorder, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
145 | 25120535 |
US |
2 | |
Infection, Fatigue, |
||||
OFATUMUMAB, |
||||
146 | 25120854 |
US |
34 | 1 |
Intestinal perforation, Infection, |
||||
UPADACITINIB, |
||||
147 | 25123472 |
73 | 2 | |
Infection, |
||||
ETANERCEPT, |
||||
148 | 25110020 |
AU |
19 | 1 |
Infection, |
||||
AVACOPAN, |
||||
149 | 25110153 |
US |
77 | 2 |
Rheumatoid arthritis, Infection, |
||||
ABATACEPT, |
||||
150 | 25110231 |
CA |
||
Brain oedema, Cardiac arrest, Neuromyelitis optica spectrum disorder, Nutritional condition abnormal, Bacteraemia, Bacterial sepsis, Cardiac failure, Endocarditis, Infection, Sepsis, |
||||
RITUXIMAB, ECULIZUMAB, ECULIZUMAB, ECULIZUMAB, ECULIZUMAB, CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
151 | 25110301 |
US |
63 | 2 |
Infection, |
||||
LENALIDOMIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
152 | 25110452 |
ES |
||
Infection, |
||||
IBRUTINIB, VENETOCLAX, |
||||
153 | 25110592 |
US |
75 | 2 |
Neoplasm progression, Febrile neutropenia, Myelosuppression, Drug ineffective for unapproved indication, Infection, |
||||
ETOPOSIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, CARBOPLATIN, THIOTEPA, |
||||
154 | 25110629 |
US |
53 | 2 |
Septic shock, Myelosuppression, Febrile neutropenia, Infection, Off label use, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, CISPLATIN, CARBOPLATIN, THIOTEPA, |
||||
155 | 25110901 |
GB |
66 | 2 |
Illness, Infection, |
||||
156 | 25110983 |
US |
75 | 2 |
Febrile neutropenia, Infection, Myelosuppression, Drug ineffective, |
||||
THIOTEPA, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, |
||||
157 | 25111105 |
US |
119 | 1 |
Myelosuppression, Febrile neutropenia, Infection, Sepsis, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, |
||||
158 | 25111179 |
US |
||
Infection, Gastrointestinal disorder, Renal disorder, Liver disorder, Febrile neutropenia, |
||||
RITUXIMAB, CARMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN, MELPHALAN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
159 | 25111296 |
US |
53 | 2 |
Myelosuppression, Septic shock, Infection, Sepsis, Febrile neutropenia, |
||||
TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, |
||||
160 | 25111407 |
CN |
||
Infection, Off label use, |
||||
ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN, |
||||
161 | 25111534 |
CA |
2 | |
Type 2 diabetes mellitus, Gait disturbance, Alopecia, Malaise, Back disorder, Fluid retention, Liver injury, Injury, Hypertension, Nausea, Sleep disorder, Memory impairment, Vomiting, Wound, Glossodynia, Hypoaesthesia, Blood cholesterol increased, Hepatic enzyme increased, Helicobacter infection, Oedema, Rash vesicular, Swelling, Abdominal discomfort, Diarrhoea, Pulmonary fibrosis, Anti-cyclic citrullinated peptide antibody positive, Stomatitis, Infusion related reaction, Pain, Breast cancer stage II, Decreased appetite, Peripheral swelling, X-ray abnormal, Pain in extremity, Grip strength decreased, Joint range of motion decreased, Dyspnoea, Pneumonia, General physical health deterioration, Dyspepsia, Psoriatic arthropathy, Mobility decreased, Pericarditis, Arthropathy, Gait inability, Joint swelling, Dislocation of vertebra, Drug hypersensitivity, Hypercholesterolaemia, Impaired healing, Condition aggravated, Psoriasis, Fatigue, Swollen joint count increased, Weight increased, Synovitis, Fibromyalgia, Folliculitis, Nasopharyngitis, Pruritus, Systemic lupus erythematosus, Infection, Abdominal pain upper, Contusion, Confusional state, Duodenal ulcer perforation, Muscle injury, Urticaria, Ill-defined disorder, Wound infection, Wheezing, Headache, Gastrointestinal disorder, Blister, Rash, Lower respiratory tract infection, Hypersensitivity, Subcutaneous drug absorption impaired, Irritable bowel syndrome, Myositis, Weight decreased, Chest pain, Sinusitis, Delirium, Discomfort, Depression, Arthralgia, Rheumatic fever, General symptom, Pemphigus, Amnesia, Migraine, Adjustment disorder with depressed mood, Sleep disorder due to general medical condition, insomnia type, Hand deformity, Musculoskeletal stiffness, Pustular psoriasis, Rheumatoid arthritis, Pyrexia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, LISINOPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RAMIPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, DESOGESTREL AND ETHINYL ESTRADIOL, CAFFEINE CITRATE, CALCIUM GLUCONATE, LORAZEPAM, ALENDRONATE SODIUM, |
||||
162 | 25111554 |
US |
210 | 1 |
Febrile neutropenia, Infection, Myelosuppression, |
||||
ETOPOSIDE, TEMOZOLOMIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
163 | 25111568 |
US |
31 | 1 |
Myelosuppression, Infection, Febrile neutropenia, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, TEMOZOLOMIDE, |
||||
164 | 25111883 |
JP |
||
Constipation, Febrile neutropenia, Infection, Pneumonia, Peripheral sensory neuropathy, Peripheral motor neuropathy, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
165 | 25111886 |
JP |
||
Infection, White blood cell count decreased, |
||||
AVACOPAN, RITUXIMAB, |
||||
166 | 25111908 |
US |
||
Escherichia infection, COVID-19, Gastrointestinal infection, Streptococcal infection, Infection parasitic, Chronic obstructive pulmonary disease, Peritonitis, Cellulitis, Urinary tract infection, Sepsis, Pneumonia, Infection, Lower respiratory tract infection, Multiple sclerosis relapse, Unevaluable event, Off label use, |
||||
RITUXIMAB, |
||||
167 | 25111944 |
US |
2 | |
Infection, Frequent bowel movements, |
||||
VEDOLIZUMAB, |
||||
168 | 25112018 |
US |
119 | 1 |
Septic shock, Myelosuppression, Febrile neutropenia, Infection, Sepsis, Off label use, |
||||
ETOPOSIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, |
||||
169 | 25112025 |
DE |
||
Breakthrough haemolysis, Blood lactate dehydrogenase increased, Infection, |
||||
RAVULIZUMAB, |
||||
170 | 25112116 |
CA |
||
Abnormal faeces, Back pain, Condition aggravated, Dental operation, Dyspepsia, Infection, Intestinal obstruction, Osteoporosis, Vomiting, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PREDNISONE, PREDNISONE, PREDNISONE, AZATHIOPRINE, MORPHINE, |
||||
171 | 25112186 |
US |
76 | 1 |
Vascular dementia, Infection, Nodule, |
||||
DUPILUMAB, DUPILUMAB, |
||||
172 | 25112496 |
US |
2 | |
Infection, |
||||
BIMEKIZUMAB, |
||||
173 | 25112711 |
|||
Infection, |
||||
RUXOLITINIB, |
||||
174 | 25112929 |
US |
2 | |
Infection, Product use in unapproved indication, |
||||
BIMEKIZUMAB, |
||||
175 | 25113094 |
US |
70 | 2 |
Sinusitis, Ear infection, Pain, Infection, Fatigue, Headache, Arthralgia, Loss of personal independence in daily activities, |
||||
BIMEKIZUMAB, SECUKINUMAB, |
||||
176 | 25113399 |
JP |
||
Disseminated intravascular coagulation, Infection, |
||||
PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, CISPLATIN, |
||||
177 | 25113476 |
US |
60 | 2 |
Joint swelling, Arthralgia, Infection, Rheumatoid arthritis, |
||||
ABATACEPT, |
||||
178 | 25113924 |
US |
||
Infection, |
||||
ADALIMUMAB, |
||||
179 | 25114018 |
CA |
60 | 2 |
Infection, Toxicity to various agents, |
||||
RITUXIMAB, |
||||
180 | 25114226 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Gastrointestinal disorder, Arthralgia, Hepatic enzyme increased, Fatigue, Hypersensitivity, Exposure during pregnancy, Pain, Pemphigus, Product use issue, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, HYDROCORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-ADAZ, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOCILIZUMAB, |
||||
181 | 25114270 |
US |
2 | |
Infection, |
||||
SARILUMAB, TESTOSTERONE, TESTOSTERONE,, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ESCITALOPRAM, CYCLOSPORINE, |
||||
182 | 25114424 |
US |
2 | |
Infection, |
||||
AGALSIDASE BETA, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, BACTERIOSTATIC WATER, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, |
||||
183 | 25114508 |
US |
62 | |
Death, Pneumonitis, Sepsis, Respiratory failure, Infection, |
||||
OLAPARIB, |
||||
184 | 25114907 |
CA |
1 | |
Infection, |
||||
CLOZAPINE, |
||||
185 | 25114957 |
GB |
||
Infection, |
||||
ELRANATAMAB-BCMM, |
||||
186 | 25115513 |
US |
||
Infection, |
||||
BACLOFEN INJECTION, |
||||
187 | 25115565 |
CA |
44 | 2 |
C-reactive protein abnormal, Inflammation, Sciatica, Injury, Joint range of motion decreased, Weight increased, Type 2 diabetes mellitus, Hypersensitivity, Glossodynia, Urticaria, Vomiting, Rheumatoid factor positive, Infusion related reaction, Helicobacter infection, Wound, Hepatic enzyme increased, Fatigue, Ill-defined disorder, Lip dry, Systemic lupus erythematosus, Sleep disorder, Duodenal ulcer perforation, Mobility decreased, Road traffic accident, Folliculitis, Rheumatoid arthritis, Fibromyalgia, Stomatitis, Liver disorder, Insomnia, Hand deformity, Malaise, Pruritus, General physical health deterioration, Infection, Swelling, Rash, Swollen joint count increased, Dry mouth, Pyrexia, Hypertension, Sleep disorder due to general medical condition, insomnia type, Psoriatic arthropathy, Synovitis, Sinusitis, Hypoaesthesia, Joint swelling, Irritable bowel syndrome, Facet joint syndrome, Wheezing, Rheumatic fever, Impaired healing, |
||||
DICLOFENAC, DICLOFENAC SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CELECOXIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, APREPITANT, FOSAPREPITANT DIMEGLUMINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE SODIUM SUCCINATE, VITAMIN C, FOLIC ACID, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, LEFLUNOMIDE, OXYCODONE, CORTISONE ACETATE, CORTISONE ACETATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, PREGABALIN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, ADALIMUMAB, GOLIMUMAB, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, TOFACITINIB, TOFACITINIB, TOFACITINIB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, APREMILAST, APREMILAST, APREMILAST, ERGOCALCIFEROL, CALCIUM CARBONATE, CALCIUM CARBONATE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DEXTROMETHORPHAN HYDROBROMIDE, CELECOXIB, CELECOXIB, USTEKINUMAB, NEOMYCIN OINTMENT, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, IODINE, PREGABALIN, PREGABALIN, GOLIMUMAB, GOLIMUMAB, SECUKINUMAB, |
||||
188 | 25118856 |
1 | ||
Infection, Swelling, Fluid retention, Intentional dose omission, |
||||
LENALIDOMIDE, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
189 | 25119371 |
71 | 2 | |
Infection, |
||||
UPADACITINIB, |
||||
190 | 25109213 |
CA |
51 | 2 |
Asthma, Head injury, Illness, Respiratory syncytial virus infection, Influenza, Infection, Pneumonia, Dizziness, Dyspnoea, Fall, Inappropriate schedule of product administration, |
||||
GABAPENTIN, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MODAFINIL, MONTELUKAST, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
191 | 25109285 |
US |
68 | 2 |
Infection, Migraine, Brain fog, Weight increased, Gastrointestinal disorder, Aphasia, Staphylococcus test positive, |
||||
TOCILIZUMAB, |
||||
192 | 25109483 |
US |
53 | 1 |
Injection site swelling, Pyrexia, Infection, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, ROSUVASTATIN, |
||||
193 | 25114461 |
71 | 2 | |
Diarrhoea, Abdominal pain, Vomiting, Infection, |
||||
LETROZOLE, |
||||
194 | 25107651 |
IE |
1 | |
Infection, Mobility decreased, |
||||
VENLAFAXINE HYDROCHLORIDE, MIRABEGRON, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, GALANTAMINE, LABETALOL HYDROCHLORIDE, LABETALOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
195 | 25107817 |
US |
50 | 2 |
Infection, Asthma, |
||||
DUPILUMAB, |
||||
196 | 25108249 |
US |
2 | |
Infection, Arthralgia, |
||||
TOCILIZUMAB, |
||||
197 | 25108293 |
JP |
||
Pyrexia, Haemolysis, Infection, Haemoglobin decreased, |
||||
RAVULIZUMAB, |
||||
198 | 25108314 |
US |
67 | 1 |
Infection, |
||||
MAVACAMTEN, |
||||
199 | 25108658 |
CA |
1 | |
Intestinal resection, Anastomotic complication, Wound, Wound infection, Infection, Diarrhoea, Impaired healing, Tracheostomy, |
||||
RISANKIZUMAB-RZAA, |
||||
200 | 25108778 |
US |
2 | |
Rheumatoid arthritis, Sinusitis, Device difficult to use, Infection, |
||||
ETANERCEPT, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28